Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Goodwill Amortizatization of Intangibles Asset Writedowns and Impairment Capital Expenditures Cash from Financing Activities Cash from Investing Activities Cash from Operations Cash from Restructuring Change in Account Payables Change in Accured Expenses Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Inventory Change in Receivables Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation and Depletion Divestments Dividends Paid - Common Exchange Rate Effect Free Cash Flow Gains from Investment Securities Long-Term Debt Repayments Net Cash Flow Net Income Non-cash Items Other Working Capital Changes Other financing activities Sales of Property, Plant and Equipment Share-based Compensation Shares Issued Short-Term Debt issuances

Daily Values

Growth Metrics

Others

Dentsply Sirona (XRAY) Gains from Sales and Divestitures (2021)

Dentsply Sirona (XRAY) has disclosed Gains from Sales and Divestitures for 3 consecutive years, with $1.5 million as the latest value for Q4 2021.

For the quarter ending Q4 2021, Gains from Sales and Divestitures changed N/A year-over-year to $1.5 million, compared with a TTM value of $1.5 million through Dec 2021, changed N/A, and an annual FY2021 reading of $1.5 million, changed N/A over the prior year.
Gains from Sales and Divestitures was $1.5 million for Q4 2021 at Dentsply Sirona, up from $174000.0 in the prior quarter.
Across five years, Gains from Sales and Divestitures topped out at $1.5 million in Q4 2021 and bottomed at $1.5 million in Q4 2021.